Comparative evaluation of hepatitis B surface antigen-loaded elastic liposomes and ethosomes for human dendritic cell uptake and immune response

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 6, Issue 1, 2010, Pages 110-118

  Mishra, Dinesh ^a   Mishra, Pradyumna Kumar ^b   Dabadghao, Sunil ^b   Dubey, Vaibhav ^a   Nahar, Manoj ^a   Jain, Narendra K ^a  

^a DR H S GOUR UNIVERSITY   (India)

^b BHOPAL MEMORIAL HOSPITAL AND RESEARCH CENTRE   (India)

Author keywords

Dendritic cells; Elastic liposomes; Ethosomes; Hepatitis B vaccine; Transcutaneous immunization

Indexed keywords

ANTIGENS; CYTOLOGY; FLOW CYTOMETRY; LIPOSOMES; LYMPHOCYTES; VACCINES;

DENDRITIC CELLS; ELASTIC LIPOSOMES; ETHOSOMES; HEPATITIS B; TRANSCUTANEOUS IMMUNIZATIONS;

IMMUNE SYSTEM;

DRUG CARRIER; ELASTIC LIPOSOME; ETHOSOME; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INTERNALIZATION; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHARMACEUTICAL ENGINEERING; T LYMPHOCYTE; VACCINE PRODUCTION;

EID: 75149154154     PISSN: 15499634     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nano.2009.04.003     Document Type: Article

References (27)

1. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 28 (2006) 112-125
2. World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 79 (2004) 255-263
3. Baumert T.F., Thimme R., and von Weizsacker F. Pathogenesis of hepatitis B virus infection. World J Gastroenterol 13 (2007) 82-90
4. Aggarwal R., Ghoshal U.C., and Naik S.R. Assessment of cost-effectiveness of universal hepatitis B immunization in a low-income country with intermediate endemicity using a Markov model. J Hepatol 38 (2003) 215-222
5. Akbar S.M.F., Horiike N., and Onji M. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection. World J Gastroenterol 12 (2006) 2876-2883
6. Shahum E., and Therien H.M.. Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells. Int Immunopharmacol 2 (2002) 591-601
7. Steinman R.M. Linking innate to adaptive immunity through dendritic cells. Novartis Found Symp 279 (2006) 216-219
8. Reddy S.T., Swartz M.A., and Hubbell J.A. Targeting dendritic cells with biomaterials: developing the next generation of vaccines. Trends Immunol 27 (2006) 573-579
9. Tacken P.J., Torensma R., and Figdor C.G. Targeting antigens to dendritic cells in vivo. Immunobiology. 211 (2006) 599-608
10. Nahar M., Dutta T., Murugesan S., Asthana A., Mishra D., Rajkumar V., et al. Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit Rev Ther Drug Carrier Syst 23 (2006) 259-318
11. Park K. Nanotechnology: What it can do for drug delivery. J Control Rel 120 (2007) 1-3
12. Mosca P.J., Lyerly H.K., Clay T.M., Morse M.A., and Lyerly H.K. Dendritic cell vaccines. Front Biosci 12 (2007) 4050-4060
13. Elsayed M.M., Abdallah O.Y., Naggar V.F., and Khalafallah N.M. Lipid vesicles for skin delivery of drugs: reviewing three decades of research. Int J Pharm 332 (2007) 1-16
14. Mishra D., Mishra P.K., Dubey V., Dabadghao S., and Jain N.K. Evaluation of uptake and generation of immune response by murine dendritic cells pulsed with hepatitis B surface antigen-loaded elastic liposomes. Vaccine. 25 (2007) 6939-6944
15. Mishra D., Dubey V., Asthana A., Saraf D.K., and Jain N.K. Elastic liposomes mediated transcutaneous immunization against hepatitis B. Vaccine. 24 (2006) 4847-4855
16. Touitou E., Dayan N., Bergelson L., Godin B., and Eliaz M. Ethosomes-novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. J Control Rel 65 (2000) 403-418
17. Dayan N., and Touitou E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials. 21 (2000) 1879-1885
18. Dubey V., Mishra D., and Jain NK. Melatonin loaded ethanolic liposomes: physicochemical characterization and enhanced transdermal delivery. Eur J Pharm Biopharm 67 (2007) 398-405
19. Dubey V., Mishra D., Nahar M., and Jain N.K. Vesicles as tools for the modulation of skin permeability. Expert Opin Drug Deliv 4 (2007) 79-93
20. Dubey V., Mishra D., Dutta T., Nahar M., Saraf D.K., and Jain N.K. Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. J Control Rel 123 (2007) 148-154
21. Mishra D., Mishra P.K., Dubey V., Nahar M., Dabadghao S., and Jain N.K. Systemic and mucosal immune response induced by transcutaneous immunization using Hepatitis B surface antigen loaded modified liposomes. Eur J Pharm Sci 33 (2008) 424-433
22. Foged C., Arigita C., Sundblad A., Jiskoot W., Storm G., and FroKjaer S. Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine. 22 (2004) 1903-1913
23. Christian Lutsiak M.E., Robinson D.R., Coester C., Kwon G.S., and Samuel J. Analysis of poly (d,l-lactic-co-glycolic acid) nanosphere uptake of human dendritic cells and macrophages in vitro. Pharm Res 19 (2002) 1480-1487
24. Huth U.S., Schubert R., and Peschka-Suss R. Investigating the uptake and intracellular fate of pH-sensitive liposomes by flow cytometry and spectral bio-imaging. J Control Rel 110 (2006) 490-504
25. Roche Diagnostics Corp. Apoptosis, cell death and proliferation. 3rd ed. (2006), Roche Diagnostics Corp., Mannheim, Germany
26. Rehermann B., and Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 5 (2005) 215-229
27. Penna A., Del Prete G., Cavalli A., Bertoletti A., D'Elios M.M., Sorrentino R., et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 25 (1997) 1022-1027